Anti-EPN1 antibody enhances the efficacy of anti-PD-L1 therapy in model of melanoma

Nov. 17, 2022

No Comments

Epsin 1 (EPN1) is an adapter protein involved in clathrin-mediated endocytosis and upregulated in multiple cancers.

BioWorld Science Conferences Cancer Immuno-oncology

Today's news in brief

BioWorld

BioWorld briefs for Jan. 24, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for January 24, 2025

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

BioWorld

The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...

Proteomics study explores how protein changes influence disease

BioWorld Science

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...

Illustration of cell receptors, antibodies

Abbvie and Simcere enter a $1B T-cell engager deal

BioWorld Asia

Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...